Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07625449 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Early Lumbar Drainage for Intraventricular Hemorrhage

Study acronym: LD-IVH
StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date: Jun 2026 to Oct 2026v2 Show 5 more changesShow less
    • Interventions modified
    • Study sites: 29 to 31
    • Eligibility criteria expanded, about 22 words
    • Secondary endpoints: 9 to 13
    • Study description shortened, about 12 words
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a multicenter, prospective, randomized, open-label, blinded-endpoint (PROBE) trial in Chinese patients with intraventricular hemorrhage (IVH), comparing early lumbar drainage added to standard care with standard care alone. The primary objective is to evaluate whether, in patients treated with external ventricular drainage (EVD) and intrathecal urokinase, the addition of early lumbar drainage improves functional outcomes at 180 days, as measured by the modified Rankin Scale (mRS), and reduces complications.
Trial Details
NCT Number NCT07625449
Lead Sponsor Second Affiliated Hospital of Nanchang University
Collaborators: Shanghai Jiao Tong University School of Medicine
Conditions
(from sponsor)		 Intraventricular Hemorrhage, Cerebral Hemorrhage
Related terms Cerebral Hemorrhage
Enrollment 392 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov